Introduction: Following a historical overview, the ovulation-inhibiting effect of various orally
administered estrogen-progestin combinations (combined oral contraceptives [COCs]) are …

The progestational and androgenic in vitro receptor binding affinity and the in vivo activity of
norgestimate was compared with that of its metabolites and other progestins. The relative …

Three new 19-nortestosterone progestogens, which are chemically related to levonorgestrel,
are now clinically available in combination oral contraceptives in Europe. Desogestrel and …

Off-target effects of drugs on nuclear hormone receptors (NHRs) may result in adverse
effects in multiple organs/physiological processes. Reliable assessments of the NHR …

Objective To investigate the effect of a triphasic low-dose oral contraceptive pill containing
gestodene on acne severity and hormone levels in young women over 13 menstrual cycles …

The efficacy, cycle control, subjective complaints, and safety of monophasic preparations of
the oral contraceptives containing gestodene 75 mcg plus ethinyl estradiol 30 mcg versus …

Preview Oral contraceptives do more than prevent pregnancy. Estrogen lowers the risk of
ovarian cancer and cysts, and progestin lowers the risk of endometrial cancer. However …

Ovulation inhibition by the monophasic oral contraceptive containing 75 μg of gestodene
and 30 wg of ethinyl estradiol was evaluated in 25 healthy volunteers for five cycles: a …

The clinical and metabolic effects of a short-term treatment with a combination contraceptive
pill containing 30 mcg ethinylestradiol and 75 mcg gestodene were evaluated in a group of …

The clinical and metabolic effects of a low-dose triphasic oral contraceptive containing
gestodene were investigated in 42 healthy women during 6 months of treatment. No …